Power consumption measurement and temperature recording during granulation

被引:40
作者
Betz, G [1 ]
Bürgin, PJ [1 ]
Leuenberger, H [1 ]
机构
[1] Univ Basel, Dept Pharm, Inst Pharmaceut Technol, CH-4056 Basel, Switzerland
关键词
granulation; power consumption; temperature control; in process control; formulation design;
D O I
10.1016/j.ijpharm.2003.12.005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This study was performed to elucidate the influences of process and formulation design using power consumption and temperature measurements during granulation. Power consumption was recorded "in process" using a previously introduced computer program for optimal end-point detection at an early stage. The temperature increase (DeltaT) during granulation was recorded using a temperature sensor. The temperature increase in the wet powder bed expresses the friction forces at interparticle contacts occurring during granulation. The maxima of temperature profile occurred at 130% saturation, whereas the maxima of power consumption were determined at 100% saturation. The ratio of temperature and power consumption (TPR factor) is introduced as a signature of formulation design. TPR factor was found to be dependent on particle size, particle surface, water absorption capacity and solubility of the excipient and model drug, respectively. However, TPR factor was found to be independent of process design, such as the filling level of the mixer. Understanding and controlling the granulation process is a key factor in robust dosage form design. The "in process" control fits ideally the prerequisites of a drug quality system for the 21st century and FDA's Process Analytical Technology (PAT) initiative. The results of previous and present works of our research group will be used in a following step to develop an artificial neural network for granulation "in process" control. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:137 / 149
页数:13
相关论文
共 23 条
[1]  
Aulton M.E., 1979, P INT C POWD TECHN P
[2]   Batch and continuous processing in the production of pharmaceutical granules [J].
Betz, G ;
Junker-Bürgin, P ;
Leuenberger, H .
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2003, 8 (03) :289-297
[3]   Power consumption profile analysis and tensile strength measurements during moist agglomeration [J].
Betz, G ;
Bürgin, PJ ;
Leuenberger, H .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 252 (1-2) :11-25
[4]  
Bier H., 1979, Die pharmazeutische inustrie, V41, P375
[5]  
Ennis BJ, 1997, PERRYS CHEM ENG HDB, V7th, P20
[6]   Process control and scale-up of pharmaceutical wet granulation processes: a review [J].
Faure, A ;
York, P ;
Rowe, RC .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2001, 52 (03) :269-277
[7]  
IMANIDIS G, 1986, THESIS BASEL U SWITZ
[8]   Nucleation, growth and breakage phenomena in agitated wet granulation processes: a review [J].
Iveson, SM ;
Litster, JD ;
Hapgood, K ;
Ennis, BJ .
POWDER TECHNOLOGY, 2001, 117 (1-2) :3-39
[9]  
Junker P., 1998, THESIS BASEL U SWITZ
[10]   MECHANICAL-PROPERTIES OF MOIST AGGLOMERATES IN RELATION TO GRANULATION MECHANISMS .1. DEFORMABILITY OF MOIST, DENSIFIED AGGLOMERATES [J].
KRISTENSEN, HG ;
HOLM, P ;
SCHAEFER, T .
POWDER TECHNOLOGY, 1985, 44 (03) :227-237